The View from 13,000 Feet: Outside Perspective on Tackling M&A and Alliances in Pharmaceuticals and Biotechnology

BTD: Making Sense of M&A, Alliances and Divestments

13-10-2020 • 42 mins

The success of Alliance-Management groups in pharmaceutical and biotechnology companies has naturally led to their involvement in M&A integrations as well. At the Association of Strategic Alliances Professionals (ASAP) Bio-Pharma Conference in September 2020, senior Alliance leaders discussed this new role.
In this episode, Mike Leonetti, ASAP CEO and Laura McCluer a leading Alliance-Management executive, discuss the major themes from those discussions with host, Nick Palmer, BTD Partner.

CLICK HERE to follow us on LinkedIn

www.btd.consulting